However, several side effects were also reported: grade 3–4 treatment-related adverse events were reported in nearly 20% of patients, diarrea in 31.7%, nausea in 19%, transaminitis (ALT and AST) in 15% and asthenia in 11.1% of cases. This evidence concerns the gene GPT and asthenia.